Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 5/2015

01.10.2015 | Short Research Report

Profiling psychotropic discharge medication from a children’s psychiatric ward

verfasst von: Gazala Akram

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Background Community prescribing of medication to treat psychiatric illness in children is increasing. However, details about medication prescribed at discharge from psychiatric inpatient services for children are scarce. Objectives Characterise the nature of psychotropic medication prescribed on discharge from a children’s psychiatric ward over a 15-year period. Method Retrospective analysis of discharge summary letters of all discharges occurring between Jan 1997 to Dec 2012. Results 234 children (152 males and 82 females) were discharged with 117 (50 %) prescribed psychotropic medication at discharge. 133 medicines were prescribed (stimulants n = 49, antipsychotics n = 31, antidepressants n = 22, mood stabilisers n = 1, other ADHD medication n = 11, melatonin n = 10, benzodiazepines n = 7, other n = 2). Risperidone was the most popular antipsychotic at a mean daily dose of 1 mg (range 0.25–4 mg). Fifty per cent were given an unlicensed medicine or a licensed drug was used in an unlicensed manner, of which risperidone was the most common (n = 14). Sleep disturbance and tics were most often treated using unlicensed/off label medication (n = 10). Conclusion Psychotropic medication is routinely used in inpatient children’s services, with the majority of use confined to stimulants and atypical antipsychotics. Much of the antipsychotic use is for unlicensed indications or at unlicensed doses.
Literatur
1.
Zurück zum Zitat Doerry UA, Kent L. Prescribing practices of community child and adolescent psychiatrists. Psychiatrist. 2003;27:407–10. Doerry UA, Kent L. Prescribing practices of community child and adolescent psychiatrists. Psychiatrist. 2003;27:407–10.
2.
Zurück zum Zitat Otasowie J, Duffy R, Freeman J, Hollis C. Antipsychotic prescribing practice among child psychiatrists and community paediatricians. Psychiatrist. 2010;34:126–9.CrossRef Otasowie J, Duffy R, Freeman J, Hollis C. Antipsychotic prescribing practice among child psychiatrists and community paediatricians. Psychiatrist. 2010;34:126–9.CrossRef
3.
Zurück zum Zitat Hsia Y, MacLennan K. Rise in psychotropic drug prescribing in children and adolescents during 1992–2001: a population-based study in the UK. Eur J Epidemiol. 2009;24:211–6.CrossRefPubMed Hsia Y, MacLennan K. Rise in psychotropic drug prescribing in children and adolescents during 1992–2001: a population-based study in the UK. Eur J Epidemiol. 2009;24:211–6.CrossRefPubMed
4.
Zurück zum Zitat Jacobs BW, Green J, Beecham J, Kroll L, Dunn G, Tobias C, et al. Two and a half thousand hours: the Children and Young Persons Inpatient Evaluation study (CHYPIE)into process and outcome of inpatient child and adolescent psychiatry. London: Department of Health; 2004. Jacobs BW, Green J, Beecham J, Kroll L, Dunn G, Tobias C, et al. Two and a half thousand hours: the Children and Young Persons Inpatient Evaluation study (CHYPIE)into process and outcome of inpatient child and adolescent psychiatry. London: Department of Health; 2004.
5.
Zurück zum Zitat Johnson J, Clark A. Prescribing of unlicensed medicines or licensed medicines for unlicensed applications in child and adolescent psychiatry. Psych Bull. 2001;25:465–6.CrossRef Johnson J, Clark A. Prescribing of unlicensed medicines or licensed medicines for unlicensed applications in child and adolescent psychiatry. Psych Bull. 2001;25:465–6.CrossRef
6.
Zurück zum Zitat Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 2009;48:884–93.PubMedCentralCrossRefPubMed Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 2009;48:884–93.PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Corell CU. Antipsychotic use in children and adolescents:minimizing adverse effects to maximise outcomes. J Am Acad Child Adoles Psychiatry. 2008;47:9–20.CrossRef Corell CU. Antipsychotic use in children and adolescents:minimizing adverse effects to maximise outcomes. J Am Acad Child Adoles Psychiatry. 2008;47:9–20.CrossRef
9.
Zurück zum Zitat Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis J, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry. 2004;161:1334–49.CrossRefPubMed Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis J, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry. 2004;161:1334–49.CrossRefPubMed
10.
Zurück zum Zitat James A, Soler A, Weatherall R. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev. 2005; 4:CD004690. James A, Soler A, Weatherall R. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev. 2005; 4:CD004690.
Metadaten
Titel
Profiling psychotropic discharge medication from a children’s psychiatric ward
verfasst von
Gazala Akram
Publikationsdatum
01.10.2015
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 5/2015
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0116-1

Weitere Artikel der Ausgabe 5/2015

International Journal of Clinical Pharmacy 5/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.